scholarly article | Q13442814 |
P50 | author | Michael Boutros | Q73877448 |
P2093 | author name string | E Hartmann | |
A Pscherer | |||
P Lichter | |||
H Döhner | |||
A Rosenwald | |||
G Ott | |||
S Stilgenbauer | |||
F Engel | |||
M Seiffert | |||
A Farfsing | |||
P2860 | cites work | Involvement of Ymer in suppression of NF-kappaB activation by regulated interaction with lysine-63-linked polyubiquitin chain | Q24301110 |
Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis | Q24307994 | ||
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen | Q24308837 | ||
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines | Q24616084 | ||
Genomic aberrations and survival in chronic lymphocytic leukemia | Q28141442 | ||
Chronic lymphocytic leukemia | Q28236621 | ||
Suppression of the ligand-mediated down-regulation of epidermal growth factor receptor by Ymer, a novel tyrosine-phosphorylated and ubiquitinated protein | Q28248770 | ||
The metabolism of proline, a stress substrate, modulates carcinogenic pathways | Q28275923 | ||
A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism | Q28282198 | ||
Expression profiling reveals off-target gene regulation by RNAi | Q29615965 | ||
Off-target effects of siRNA specific for GFP | Q33346459 | ||
In vivo measurements document the dynamic cellular kinetics of chronic lymphocytic leukemia B cells | Q33830733 | ||
A20 and A20-binding proteins as cellular inhibitors of nuclear factor-kappa B-dependent gene expression and apoptosis | Q34047242 | ||
A polymorphic microsatellite that mediates induction of PIG3 by p53. | Q34120918 | ||
Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes | Q34130791 | ||
Cloning of the chromosome breakpoint of neoplastic B cells with the t(14;18) chromosome translocation | Q34245495 | ||
Mutation and genomic deletion status of ataxia telangiectasia mutated (ATM) and p53 confer specific gene expression profiles in mantle cell lymphoma | Q34479078 | ||
Integrated genomic and expression profiling in mantle cell lymphoma: identification of gene-dosage regulated candidate genes. | Q34807976 | ||
Mantle cell lymphoma is characterized by inactivation of the ATM gene | Q35081325 | ||
Specific chromosomal imbalances in human papillomavirus-transfected cells during progression toward immortality | Q36106455 | ||
The chromosome 14 breakpoint in neoplastic B cells with the t(11;14) translocation involves the immunoglobulin heavy chain locus | Q36264870 | ||
Update on the molecular biology of mantle cell lymphoma | Q36364527 | ||
Specific secondary genetic alterations in mantle cell lymphoma provide prognostic information independent of the gene expression-based proliferation signature | Q36629194 | ||
Advances in the understanding of mantle cell lymphoma | Q37137955 | ||
Molecular diagnostics in chronic lymphocytic leukemia - pathogenetic and clinical implications | Q37152757 | ||
p53 polymorphisms: cancer implications | Q37376012 | ||
Treatment resistance in chronic lymphocytic leukemia: the role of the p53 pathway | Q37434174 | ||
Inhibition of NF-kappaB signaling via tyrosine phosphorylation of Ymer. | Q39908451 | ||
Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids | Q40105838 | ||
Homozygous deletions localize novel tumor suppressor genes in B-cell lymphomas | Q40234300 | ||
Antagonizing inactivated tumor suppressor genes and activated oncogenes by a versatile transgenesis system: application in mantle cell lymphoma | Q40288213 | ||
Genome-wide array-based CGH for mantle cell lymphoma: identification of homozygous deletions of the proapoptotic gene BIM. | Q40479135 | ||
Comprehensive whole genome array CGH profiling of mantle cell lymphoma model genomes. | Q40540010 | ||
Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector | Q40773079 | ||
Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis | Q44484550 | ||
Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome | Q44730863 | ||
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV. | Q46209291 | ||
Identification of progression markers in B-CLL by gene expression profiling | Q46614433 | ||
Designing effective siRNAs with off-target control | Q51582278 | ||
Investigatory and analytical approaches to differential gene expression profiling in mantle cell lymphoma | Q52026719 | ||
A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma | Q53855330 | ||
Gene expression profiling of mantle cell lymphoma cells reveals aberrant expression of genes from the PI3K-AKT, WNT and TGFbeta signalling pathways. | Q54648964 | ||
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma | Q57279573 | ||
t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia | Q73459806 | ||
Altered apoptosis pathways in mantle cell lymphoma detected by oligonucleotide microarray | Q74250057 | ||
Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma | Q74480204 | ||
Identification of genes whose expression patterns differ in benign lymphoid tissue and follicular, mantle cell, and small lymphocytic lymphoma | Q76312993 | ||
Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status | Q80809839 | ||
Novel chromosomal imbalances in mantle cell lymphoma detected by genome-wide array-based comparative genomic hybridization | Q80894677 | ||
Genomic aberrations in mantle cell lymphoma detected by interphase fluorescence in situ hybridization. Incidence and clinicopathological correlations | Q80958713 | ||
P433 | issue | 11 | |
P921 | main subject | leukemia | Q29496 |
mantle cell lymphoma | Q268713 | ||
lymphocyte | Q715347 | ||
P304 | page(s) | 2018-2026 | |
P577 | publication date | 2009-07-30 | |
P1433 | published in | Leukemia | Q6534498 |
P1476 | title | Gene knockdown studies revealed CCDC50 as a candidate gene in mantle cell lymphoma and chronic lymphocytic leukemia | |
P478 | volume | 23 |
Q90362958 | A Coiled-Coil Domain Containing 50 Splice Variant Is Modulated by Serine/Arginine-Rich Splicing Factor 3 and Promotes Hepatocellular Carcinoma in Mice by the Ras Signaling Pathway |
Q96952353 | A novel selective autophagy receptor, CCDC50, delivers K63 polyubiquitination-activated RIG-I/MDA5 for degradation during viral infection |
Q41846273 | Coiled-coil domain containing 109B is a HIF1α-regulated gene critical for progression of human gliomas |
Q104073761 | Coiled-coil domain containing 50-V2 protein positively regulates neurite outgrowth |
Q95660674 | Combining gene expression profiling and machine learning to diagnose B-cell non-Hodgkin lymphoma |
Q39105456 | Defective DROSHA processing contributes to downregulation of MiR-15/-16 in chronic lymphocytic leukemia |
Q30408034 | Generation of BAC transgenic tadpoles enabling live imaging of motoneurons by using the urotensin II-related peptide (ust2b) gene as a driver |
Q45188801 | Genome-wide scan on total serum IgE levels identifies no common variants in a healthy Chinese male population |
Q39229600 | High expression of crystallin αB represents an independent molecular marker for unfavourable ovarian cancer patient outcome and impairs TRAIL- and cisplatin-induced apoptosis in human ovarian cancer cells. |
Q96606076 | HnRNP A1 - mediated alternative splicing of CCDC50 contributes to cancer progression of clear cell renal cell carcinoma via ZNF395 |
Q41072852 | Identification of subtype specific miRNA-mRNA functional regulatory modules in matched miRNA-mRNA expression data: multiple myeloma as a case. |
Q48027440 | Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall |
Q39375022 | Super-SILAC Allows Classification of Diffuse Large B-cell Lymphoma Subtypes by Their Protein Expression Profiles |
Q38315575 | ZRANB2 localizes to supraspliceosomes and influences the alternative splicing of multiple genes in the transcriptome |
Search more.